Company Number: 13133250

Analysis Date: 2025-07-20 13:12 UTC

1. Industry Classification

Mykor Ltd operates primarily within SIC code 72190, which pertains to "Other research and experimental development on natural sciences and engineering," and also holds SIC code 16290, "Manufacture of other products of wood; manufacture of articles of cork, straw and plaiting materials." This dual classification positions Mykor at the intersection of innovative biotech research and sustainable manufacturing, specifically producing low-carbon mycelium insulation. The sector characteristics include a strong emphasis on R&D investment, sustainable material innovation, and niche manufacturing targeting eco-friendly construction and insulation markets.

2. Relative Performance

As a private limited company incorporated in 2021 and filing under the Total Exemption Full category, Mykor Ltd is a small-scale yet rapidly developing business. The latest financials for the year ended 31 December 2023 show a significant turnaround from prior years: net assets improved from a negative £35,373 in 2022 to a positive £562,289 in 2023. This is driven largely by a substantial increase in debtors (from £3,543 to £548,517) and current assets, indicating either expanded sales on credit or related-party receivables, possibly from subsidiaries or partnerships. The company holds relatively modest fixed assets (£25,927), consistent with a biotech manufacturing startup that relies more on intellectual property and R&D than heavy equipment.

Compared to typical industry benchmarks for small-scale biotech and sustainable manufacturing firms, Mykor's rapid asset growth and positive net asset position within three years is promising, especially given the niche market of mycelium insulation. However, the high level of debtors relative to cash (£17,536) suggests working capital management could be an area for improvement, as industry norms often prefer higher liquidity ratios to mitigate operational risks.

3. Sector Trends Impact

The natural sciences R&D and sustainable construction materials sectors are currently influenced by several key trends:

• Sustainability and Carbon Reduction: Increasing regulatory and consumer demands for low-carbon building materials strongly benefit Mykor's product offering. Mycelium insulation is gaining traction due to its biodegradability and low embodied carbon.

• Innovation in Biotech Manufacturing: Advances in biotech enable scalable production of novel materials, but require ongoing R&D investment and regulatory approvals, which can constrain cash flows for smaller players.

• Supply Chain and Raw Material Availability: The production depends on biomass inputs, which are subject to fluctuations in supply and cost. Effective sourcing and supply chain resilience are critical.

• Market Adoption: As the building and construction industry shifts toward green certifications, companies like Mykor are well-positioned but must compete against established insulation materials and alternative green tech.

Overall, these trends create a favourable environment for growth but also impose pressures related to capital intensity, innovation cycles, and market education.

4. Competitive Positioning

Mykor Ltd appears to be a niche player focused on an emergent segment of environmentally sustainable insulation products. Strengths include:

• Innovative Product Offering: Mycelium-based insulation is a cutting-edge, low-carbon alternative in the construction materials market.

• R&D Focus: The classification under experimental development aligns with ongoing innovation capacity.

• Positive Financial Trajectory: The company has reversed earlier losses and built a strong asset base in a short timeframe.

Potential weaknesses relative to typical competitors include:

• Scale and Market Penetration: As a relatively new and small enterprise, Mykor likely faces challenges in scaling manufacturing, distribution, and brand recognition against larger, established insulation manufacturers.

• Working Capital and Liquidity: The large debtor balance and relatively low cash reserves may constrain operational flexibility. Industry peers often maintain stronger cash flows or diversified financing to support growth.

• Dependence on Key Individuals: Control is concentrated between two significant shareholders and a small directorship, which may limit governance diversity and strategic resilience.

In summary, Mykor Ltd fits the profile of an innovative, early-stage sustainable materials manufacturer with promising financial turnaround and strong alignment with sector trends but faces typical growth and liquidity challenges common to niche biotech startups in competitive construction supply markets.